Moderna shares $MRNA fell roughly 8% after the market close after the company announced that the U.S. regulator FDA declined to start a review of its application to approve the influenza vaccine mRNA-1010...

Here it is, ladies and gentlemen. Today we’re heading downhill — $SPGI cut its outlook, even though the numbers beat expectations, and the stock is already feeling it; of course it’s being followed by $MSCI and others.

So what exactly were SPGI’s results and is the stock’s decline justified? We’re reaching unprecedented levels.

Thanks

SpaceX wants to build a base on the Moon. And the market is already thinking about only one thing: When will the IPO happen?

SpaceX wants to build a base on the Moon. And the market is already thinking about only one thing: When will the IPO come?